In the current volatile environment, failures can lead to permanent losses and dodging losers may be more important than backing winners....

T. Rowe Price has shared the three healthcare stocks it is banking on to benefit from COVID-19 but warns it may be years before a vaccine is developed. ...

Australian equity performance does not reflect the strong COVID-19 crisis response by the country, making a catch-up rally likely in the future, according to T. Rowe Pric...

T. Rowe Price has announced it has lowered the fee structure for its flagship Australian Unit Trust – Global Equity fund....

Although we may enter a recession over the next couple of quarters, there are key signals to look for that will signify the crisis hitting its peak, according to a T. Row...

2019 was a strong year for equities, but according to a T. Rowe Price portfolio manager that momentum won’t always last, so fundamentals and stock selection will be impor...

T. Rowe Price has announced leadership transitions for its Asia Pacific distribution business, effective 1 January next year. ...

While volatility is expected to persist moving into the second half of 2018, this will potentially produce attractive buying opportunities for long-term investors, accord...